Next Article in Journal
Die Kardiologen und die Zukunft ihres Fachs
Previous Article in Journal
Instantaneous Wave-Free Ratio: An Adenosine-Independent Index to Guide Coronary Revascularisation
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cardiovascular Medicine
Volume 21
Issue 7-8
10.4414/cvm.2018.00556
cardiovascmed-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

New Compounds for the Treatment of Pulmonary Hypertension

by
Roger Hullin
Service de Cardiologie, Département Coeur-Vaisseaux, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, CH-1011 Lausanne, Switzerland
Cardiovasc. Med. 2018, 21(7-8), 195; https://doi.org/10.4414/cvm.2018.00556
Submission received: 7 May 2018 / Revised: 7 June 2018 / Accepted: 7 July 2018 / Published: 7 August 2018
Versions Notes

Abstract

Survival with pulmonary arterial hypertension has significantly improved in the last two decades with the development and approval of different compounds. This review highlights the properties of molecules that more recently became available for specific treatment of pulmonary hypertension.
Keywords: pulmonary arterial hypertension; endothelin receptor antagonist; soluble guanylate cyclase stimulator; prostacyclin receptor agonist pulmonary arterial hypertension; endothelin receptor antagonist; soluble guanylate cyclase stimulator; prostacyclin receptor agonist

Share and Cite

MDPI and ACS Style

Hullin, R. New Compounds for the Treatment of Pulmonary Hypertension. Cardiovasc. Med. 2018, 21, 195. https://doi.org/10.4414/cvm.2018.00556

AMA Style

Hullin R. New Compounds for the Treatment of Pulmonary Hypertension. Cardiovascular Medicine. 2018; 21(7-8):195. https://doi.org/10.4414/cvm.2018.00556

Chicago/Turabian Style

Hullin, Roger. 2018. "New Compounds for the Treatment of Pulmonary Hypertension" Cardiovascular Medicine 21, no. 7-8: 195. https://doi.org/10.4414/cvm.2018.00556

APA Style

Hullin, R. (2018). New Compounds for the Treatment of Pulmonary Hypertension. Cardiovascular Medicine, 21(7-8), 195. https://doi.org/10.4414/cvm.2018.00556

Article Metrics

Back to TopTop